Issue |
J Extra Corpor Technol
Volume 29, Number 1, March 1997
|
|
---|---|---|
Page(s) | 25 - 29 | |
DOI | https://doi.org/10.1051/ject/199729125 | |
Published online | 18 August 2023 |
Original Article
Adding Hetastarch to the Adult Cardiopulmonary Bypass Prime Does Not Affect Patient Outcomes
Program of Extracorporeal Circulation Technology, College of Health Professions, Medical University of South Carolina, Charleston, South Carolina
* Address correspondence to: Melany Boykin, BS, CRTT Medical University of South Carolina Program of Extracorporeal Circulation Technology 101 Doughty Street, 2nd Floor Charleston, SC 29425
Hespan™ (hetastarch), a synthetic colloid, is often used in priming cardiopulmonary bypass circuits. The purpose of this study is to determine the efficacy of adding hetastarch to the prime compared to adding no hetastarch. Twenty-four adult patients undergoing cardiopulmonary bypass received Hespan™ in the prime, while twenty-nine patients did not. Outcomes were compared using paired t-test, analysis of variance, analysis of covariance, and descriptive statistics, where p<0.05 was considered significant. There were no significant differences in change in lung compliance, weight gain, time on the ventilator, or length of stay in the intensive care unit. Adding colloids to the adult CPB prime does not improve patient outcomes over priming exclusively with crystalloids.
Key words: hetastarch / lung compliance / cardiopulmonary bypass / ventilator time / volume status / weight gain
© 1997 AMSECT
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.